Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Hypoxia-inducible factor-1 (HIF-1) is a transcriptional complex that controls cellular and systemic homeostatic responses to oxygen availability. HIF-1 alpha is the oxygen-regulated subunit of HIF-1, an alpha beta heterodimeric complex. HIF-1 alpha is stable in hypoxia, but in the presence of oxygen it is targeted for proteasomal degradation by the ubiquitination complex pVHL, the protein of the von Hippel Lindau (VHL) tumour suppressor gene and a component of an E3 ubiquitin ligase complex. Capture of HIF-1 alpha by pVHL is regulated by hydroxylation of specific prolyl residues in two functionally independent regions of HIF-1 alpha. The crystal structure of a hydroxylated HIF-1 alpha peptide bound to VCB (pVHL, elongins C and B) and solution binding assays reveal a single, conserved hydroxyproline-binding pocket in pVHL. Optimized hydrogen bonding to the buried hydroxyprolyl group confers precise discrimination between hydroxylated and unmodified prolyl residues. This mechanism provides a new focus for development of therapeutic agents to modulate cellular responses to hypoxia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under normoxia, PHDs hydroxylate conserved proline residues within HIF-α subunits, increasing their affinity for the von Hippel–Lindau (pVHL) E3 ubiquitin ligase complex, which promotes polyubiquitination and 26S proteasomal degradation”
From HIF inhibition: Current strategies and clinical challenges (2026) · cites this paper as [44]
In the citing paper
“The subsequent discovery of a peptide from hypoxia-inducible factor 1 subunit-α (HIF1α) that bound the E3 ligase von Hippel–Lindau tumour suppressor (VHL)18,19 led to the design of cell-penetrating PROTACs that degraded a range of POIs.”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [18]
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648 · cited 1×
“Cycles of rebuilding and refinement were carried out using the programs”
MethodHershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Self-citationAQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Research works printed but not linked: 1
- Hubbard, S. J. & Thornton, J. M. ‘NACCESS’, Computer Program Version 2.1.1 (Department of Biochemistry and Molecular Biology, Univ. Coll. London, London, 1996)
Cited by
Items 301–400 of 770
Hypoxia in aquatic invertebrates: Occurrence and phenotypic and molecular responses
Lee, Y., Byeon, E., Kim, D., Maszczyk, P., Wang, M., Wu, R. S. S., Jeung, H.-D., Hwang, U.-K., & Lee, J. (2023) · Aquatic Toxicology · doi:10.1016/j.aquatox.2023.106685 · Cited by 54
Modulation of the Hypoxic Response
Pugh, C. W. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-7678-9_18 · Cited by 61
Self-citationKhan, Z., Michalopoulos, G. K., & Stolz, D. B. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060360 · Cited by 60
Miller, F., Kentsis, A., Osman, R., & Pan, Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m413160200 · Cited by 58
Liu, S., Wang, J., Peng, S., Li, T., Ning, X., Hong, B., Liu, J., Wu, P., Zhou, B., Zhou, J., et al. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.261 · Cited by 53
Protein degradation and iron homeostasis
Thompson, J. W., & Bruick, R. K. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.02.003 · Cited by 55
Signaling pathways and targeted therapy for pulmonary hypertension
Adu‐Amankwaah, J., Shi, Y., Song, H., Ma, Y., Liu, J., Wang, H., Yuan, J., Sun, K., Hu, Q., & Tan, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02287-8 · Cited by 63
Activation of hypoxia-induced transcription in normoxia
Hägg, M., & Wennström, S. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.01.017 · Cited by 57
Ha, S., Luo, G., & Xiang, H. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01487 · Cited by 49
Small-Molecule Approaches to Targeted Protein Degradation
Faust, T. B., Donovan, K. A., Yue, H., Chamberlain, P. P., & Fischer, E. S. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-051420-114114 · Cited by 44
Hasanov, E., & Jonasch, E. W. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1925248 · Cited by 50
SM-20, EGL-9, and the EGLN Family of Hypoxia-inducible Factor Prolyl Hydroxylases
Freeman, R. S., Hasbani, D. M., Lipscomb, E. A., Straub, J. A., & Xie, L. (2003) · Molecules and Cells · doi:10.1016/s1016-8478(23)13758-7 · Cited by 52
The Role of HIF-1α in Bone Regeneration: A New Direction and Challenge in Bone Tissue Engineering
You, J., Liu, M., Li, M., Zhai, S., Quni, S., Zhang, L., Liu, X., Jia, K., Zhang, Y., & Zhou, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098029 · Cited by 63
Delivery of miR-155 to retinal pigment epithelial cells mediated by Burkitt’s lymphoma exosomes
Yoon, C., Kim, J., Park, G., Kim, S., Kim, D., Hur, D. Y., Kim, B., & Kim, Y. S. (2015) · Tumor Biology · doi:10.1007/s13277-015-3769-4 · Cited by 46
VHLdb: A database of von Hippel-Lindau protein interactors and mutations
Tabaro, F., Minervini, G., Sundus, F., Quaglia, F., Leonardi, E., Piovesan, D., & Tosatto, S. C. E. (2016) · Scientific Reports · doi:10.1038/srep31128 · Cited by 50
Bonardi, A., Bua, S., Combs, J. E., Lomelino, C. L., Andring, J. T., Osman, S. M., Toti, A., Mannelli, L. D. C., Gratteri, P., Ghelardini, C., et al. (2022) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2053526 · Cited by 45
Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues
Hassan, M. M., Li, Y.-D., Ma, M. W., Teng, M., Byun, W. S., Puvar, K., Lumpkin, R. J., Sandoval, B., Rutter, J. C., Jin, C. Y., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116904 · Cited by 47
Heessen, S., Dantuma, N. P., Tessarz, P., Jellne, M., & Masucci, M. G. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01296-1 · Cited by 44
Patel, N. N., & Kalra, V. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.119495 · Cited by 48
Lucas, X., Van Molle, I., & Ciulli, A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00842 · Cited by 42
HIF-2α-pVHL complex reveals broad genotype-phenotype correlations in HIF-2α-driven disease
Tarade, D., Robinson, C. M., Lee, J. E., & Ohh, M. (2018) · Nature Communications · doi:10.1038/s41467-018-05554-1 · Cited by 48
Solution Structure of the Human Ubiquitin-specific Protease 15 DUSP Domain
de Jong, R. N., Eiso, A. B., Diercks, T., Truffault, V., Daniëls, M., Kaptein, R., & Folkers, G. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510993200 · Cited by 51
Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)
Wang, H., Zhou, R., Xu, F., Yang, K., Zheng, L., Zhao, P., Shi, G., Dai, L., Xu, C., Yu, L., et al. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00385-8 · Cited by 51
Prolyl-4-hydroxylase 2 and 3 coregulate murine erythropoietin in brain pericytes
Urrutia, A. A., Afzal, A., Nelson, J., Davidoff, O., Gross, K. W., & Haase, V. H. (2016) · Blood · doi:10.1182/blood-2016-05-713545 · Cited by 48
Li, D., Hirsilä, M., Koivunen, P., Brenner, M. C., Xu, L., Yang, C., Kivirikko, K. I., & Myllyharju, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410287200 · Cited by 43
Correlations between predicted protein disorder and post-translational modifications in plants
Kurotani, A., Tokmakov, A. A., Kuroda, Y., Fukami, Y., Shinozaki, K., & Sakurai, T. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt762 · Cited by 49
“Protein disorder was suggested to facilitate hydroxylation of proline residues (Hon et al., 2002).”
BackgroundTranscriptional Regulation of Serine/Threonine Kinase-15 (STK15) Expression by Hypoxia and HIF-1
Klein, A. M., Flügel, D., & Kietzmann, T. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-01-0042 · Cited by 49
Genetic causes of erythrocytosis and the oxygen-sensing pathway
Lee, F. S. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.04.003 · Cited by 47
Hypoxia inducible factor (HIF) as a model for studying inhibition of protein–protein interactions
Burslem, G. M., Kyle, H. F., Nelson, A., Edwards, T. A., & Wilson, A. J. (2017) · Chemical Science · doi:10.1039/c7sc00388a · Cited by 39
Setia, N., Almuqdadi, H. T. A., & Abid, M. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116041 · Cited by 45
Selective Elimination of Senescent Cancer Cells by Galacto-Modified PROTACs
Chang, M., Gao, F., Gnawali, G. R., Xu, H., Dong, Y., Meng, X., Li, W., Wang, Z., Lopez, B., Carew, J. S., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00152 · Cited by 44
Chimeric Molecules to Target Proteins for Ubiquitination and Degradation
Sakamoto, K. M. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)99054-x · Cited by 42
VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo
Lee, C. M., Hickey, M. M., Sanford, C. A., McGuire, C., Cowey, C. L., Simon, M. C., & Rathmell, W. K. (2009) · Oncogene · doi:10.1038/onc.2009.12 · Cited by 46
HIF-1: An Age-Dependent Regulator of Lens Cell Proliferation
Shui, Y., Arbeit, J. M., Johnson, R. S., & Beebe, D. C. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2118 · Cited by 45
“The HIF-1 transgenes used were human HIF-1 cDNAs in which prolines 402 and 564 were mutated to alanine and glycine, respectively, or in which the entire ODD was deleted (K14-HIF-1 -Pro and K14-HIF-1 ODD, respectively).(14,42,45) Both 1- and 8-month-old transgenic mice had elevated levels of HIF1 in lens epithelial cel…”
MethodNuclear-cytoplasmatic shuttling of proteins in control of cellular oxygen sensing
Depping, R., JELKMANN, W. E. B., & Kosyna, F. K. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1276-0 · Cited by 44
Chemical Protein Degradation Approach and its Application to Epigenetic Targets
Itoh, Y. (2018) · The Chemical Record · doi:10.1002/tcr.201800032 · Cited by 42
Maneiro, M., Vita, E. D., Conole, D., Kounde, C. S., Zhang, Q., & Tate, E. W. (2021) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2021.01.002 · Cited by 41
Katschinski, D. M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01952.x · Cited by 46
“Binding of pVHL strictly requires prior modification of human HIF-1a or HIF-2a by prolyl-4-hydroxylation at prolines 402 and 564 or prolines 405 or 531 respectively (Hon et al. 2002, Min et al. 2002).”
MethodSemenza, G. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192442299 · Cited by 44
U19/Eaf2 Binds to and Stabilizes von Hippel-Lindau Protein
Xiao, W., Ai, J., Habermacher, G. M., Volpert, O. V., Yang, X. J., Zhang, A.-Y., Hahn, J., Cai, X., & Wang, Z. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2595 · Cited by 39
Murray, J. K., Chenera, B., Allgeier, A. M., Kasparian, A. J., Viswanadhan, V. N., Wilde, C., Allen, J. R., Yoder, S. C., Biddlecome, G. H., Hungate, R. W., et al. (2010) · Journal of Combinatorial Chemistry · doi:10.1021/cc100073a · Cited by 44
Straub, J. A., Lipscomb, E. A., Yoshida, E. S., & Freeman, R. S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01688.x · Cited by 38
“Proline hydroxylation, possibly catalyzed by one or more SM-20 family members, appears to stimulate HIF-1a degradation by enhancing its affinity for the von Hippel–Lindau protein, the substrate recognition subunit for an E3 ubiquitin ligase (Hon et al. 2002; Min et al. 2002).”
BackgroundTang, Y.-Q., Han, B.-M., Yao, X.-Q., Hong, Y., Wang, Y., Zhao, F.-J., Yu, S.-Q., Sun, X.-W., & Xia, S.-J. (2009) · Asian Journal of Andrology · doi:10.1038/aja.2008.26 · Cited by 35
Kinderlerer, A. R., Steinberg, R., Johns, M. S., Harten, S. K., Lidington, E. A., Haskard, D. O., Maxwell, P. H., & Mason, J. C. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2019 · Cited by 38
Self-citationProceedings of the Oxygen Homeostasis/Hypoxia Meeting
Kaufman, B., Scharf, O., Arbeit, J., Ashcroft, M., Brown, J. M., Bruick, R. K., Chapman, J. D., Evans, S. M., Giaccia, A. J., Harris, A. L., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2611 · Cited by 38
Self-citationOptical analysis of the HIF‐1 complex in living cells by FRET and FRAP
Wotzlaw, C., Otto, T., Berchner‐Pfannschmidt, U., Metzen, E., Acker, H., & Fandrey, J. (2006) · The FASEB Journal · doi:10.1096/fj.06-6280com · Cited by 42
Two new mutations in the HIF2A gene associated with erythrocytosis
Percy, M. J., Chung, Y. J., Harrison, C., Mercieca, J., Hoffbrand, A. V., Dinardo, C. L., Santos, P. C. J. L., Fonseca, G. H. H., Gualandro, S. F. M., Pereira, A. C., et al. (2012) · American Journal of Hematology · doi:10.1002/ajh.23123 · Cited by 37
Belzutifan: a novel therapeutic for the management of von Hippel–Lindau disease and beyond
Curry, L. C., & Soleimani, M. (2024) · Future Oncology · doi:10.2217/fon-2023-0679 · Cited by 43
Leu-574 of HIF-1α Is Essential for the von Hippel-Lindau (VHL)-mediated Degradation Pathway
Huang, L. E., Pete, E. A., Schau, M., Milligan, J., & Gu, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207280200 · Cited by 37
He, W., Batty-Stuart, S., Lee, J. E., & Ohh, M. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167244 · Cited by 43
Drug Discovery Approaches to Target E3 Ligases
Rodríguez-Gimeno, A., & Galdeano, C. (2024) · ChemBioChem · doi:10.1002/cbic.202400656 · Cited by 45
A Synthetic Oxygen Sensor for Plants Based on Animal Hypoxia Signaling
Iacopino, S., Jurinovich, S., Cupellini, L., Piccinini, L., Cardarelli, F., Pierdomenico Perata, A., Mennucci, B., Giuntoli, B., & Licausi, F. (2018) · PLANT PHYSIOLOGY · doi:10.1104/pp.18.01003 · Cited by 37
Oehme, F., Jonghaus, W., Narouz-Ott, L., Hütter, J. F., & Flamme, I. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.03.066 · Cited by 40
Huang, Q., Chang, J., Cheung, M. K., Nong, W., Li, L., Lee, M.-T., & Kwan, H. S. (2014) · Journal of Proteome Research · doi:10.1021/pr401019d · Cited by 38
VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma
Ganner, A., Gehrke, C., Klein, M., Thegtmeier, L., Matulenski, T., Wingendorf, L., Wang, L., Pilz, F., Greidl, L., Meid, L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94132-5 · Cited by 41
A comprehensive review of BET-targeting PROTACs for cancer therapy
Zhou, X., Zhao, F., Xu, Y.-T., Guan, Y., Yu, T., Zhang, Y., Duan, Y., & Zhao, Y. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.117033 · Cited by 40
The Daam2–VHL–Nedd4 axis governs developmental and regenerative oligodendrocyte differentiation
Ding, X., Jo, J.-Y., Wang, C., Cristobal, C. D., Zuo, Z., Ye, Q., Wirianto, M., Lindeke-Myers, A., Choi, J. M., Mohila, C., et al. (2020) · Genes & Development · doi:10.1101/gad.338046.120 · Cited by 37
“While the relationship of E3 ubiquitin ligase VHL and its substrate HIF has been well established across a host of developmental and disease conditions, includingWMI (Maher and Kaelin 1997; Cockman et al. 2000; Ivan et al. 2001; Hon et al. 2002; Kaelin 2002; Yuen et al. 2014), the mechanisms upstream of VHL are not we…”
BackgroundWhat influences the activity of Degrader−Antibody conjugates (DACs)
Guo, Y., Li, X., Xie, Y., & Wang, D. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116216 · Cited by 40
Concise Review: Genetic Dissection of Hypoxia Signaling Pathways in Normal and Leukemic Stem Cells
Gezer, D., Vukovic, M., Soga, T., Pollard, P. J., & Kranc, K. R. (2014) · Stem Cells · doi:10.1002/stem.1657 · Cited by 38
The CRL2LRR-1 ubiquitin ligase regulates cell cycle progression during C. elegans development
Merlet, J., Burger, J., Tavernier, N., Richaudeau, B., Gomes, J., & Pintard, L. (2010) · Development · doi:10.1242/dev.054866 · Cited by 34
Elevated glucose increases genomic instability by inhibiting nucleotide excision repair
Ciminera, A. K., Shuck, S. C., & Termini, J. S. (2021) · Life Science Alliance · doi:10.26508/lsa.202101159 · Cited by 34
“Hydroxylation of HIF-1 α at prolines 402 and 564 by PHDs facilitates binding to the Von-Hippel Lindau E3 ubiquitin ligase (pVHL-E3), inducing polyubiquitination and proteasomal degradation (Hon et al, 2002; Min et al, 2002).”
Feeding the machine: mechanisms of proteasome-catalyzed degradation of ubiquitinated proteins
Crews, C. M. (2003) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2003.08.002 · Cited by 39
Protein degraders - from thalidomide to new PROTACs
Ito, T. (2023) · The Journal of Biochemistry · doi:10.1093/jb/mvad113 · Cited by 36
Kang, H. M., Noh, K. H., Chang, T. K., Park, D., Cho, H., Lim, J. H., & Jung, C. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1520-6 · Cited by 34
Torales‐Cardeña, A., Martínez-Torres, I., Rodríguez–Martínez, S., Gómez‐Chávez, F., Cancino‐Díaz, J. C., Vázquez-Sánchez, E. A., & Cancino-Diaz, M. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/607363 · Cited by 219
Chemical Approaches to Controlling Intracellular Protein Degradation
Schneekloth, J. S., & Crews, C. M. (2005) · ChemBioChem · doi:10.1002/cbic.200400274 · Cited by 36
Protein kinase C‐δ regulates the stability of hypoxia‐inducible factor‐1α under hypoxia
Lee, J., Park, J. A., Kim, S., Seo, J. H., Lim, K., Jeong, J., Jeong, C., Chun, K., Lee, S., Kwon, Y., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00535.x · Cited by 35
Emerging drug design strategies in anti-influenza drug discovery
Liu, C., Hu, L., Dong, G., Zhang, Y., da Silva‐Júnior, E. F., Liu, X., Menéndez‐Arias, L., & Zhan, P. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.08.010 · Cited by 37
“Therefore, ALAPYIP is bound to E3 ubiquitin ligase and then degraded by proteasome 76,77 .”
BackgroundMethodMalarvannan, M., Unnikrishnan, S., Monohar, S., Ravichandiran, V., & Paul, D. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107984 · Cited by 35
Small molecule-mediated protein knockdown as a new approach to drug discovery
Tinworth, C. P., Lithgow, H., & Churcher, I. (2016) · MedChemComm · doi:10.1039/c6md00347h · Cited by 31
Abboud, M. I., McAllister, T. E., Leung, I. K. H., Chowdhury, R., Jorgensen, C., Domene, C., Mecinović, J., Lippl, K., Hancock, R. L., Hopkinson, R. J., et al. (2018) · Chemical Communications · doi:10.1039/c8cc00387d · Cited by 31
Self-citationNeddylation: A Versatile Pathway Takes on Chronic Liver Diseases
Yao, J., Liang, X. Y., Liu, Y., & Zheng, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.586881 · Cited by 34
Telomere Targeting Chimera Enables Targeted Destruction of Telomeric Repeat-Binding Factor Proteins
Wang, Z., Liu, J., Chen, H., Qiu, X., Xie, L., Kanıskan, H. Ü., Chen, X., Jin, J. J., & Wei, W. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c02783 · Cited by 37
Internal En Bloc Resection and Genetic Analysis of Retinal Capillary Hemangioblastoma
Schlesinger, T. K., Appukuttan, B., Hwang, T., Atchaneeyakasul, L.-O., Chan, C.-C., Zhuang, Z., Stout, J. T., & Wilson, D. J. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.9.1189 · Cited by 34
“When mutated, the VHL gene produces a protein that is unable to regulate hypoxia-inducible factor, permitting accumulation of hypoxia-inducible factor and subsequent activation of vascular endothelial growth factor and other hypoxiainducible genes.(5,6) This can result in growth of retinal hemangioblastomas and other…”
BackgroundGenetically heterogeneous origins of idiopathic erythrocytosis
Percy, M. J. (2007) · Hematology · doi:10.1080/10245330601111979 · Cited by 35
“Although Pr0582 is conserved within mammalian species it is not in amphibians, with Ser582 being the common variant in these species [70].”
BackgroundBiochemistry of the hypoxia-inducible factor hydroxylases
Fiorini, G., & Schofield, C. J. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2024.102428 · Cited by 35
Self-citationSalvaris, R., Brennan, J., & Lewis, K. L. (2025) · Cancers · doi:10.3390/cancers17030557 · Cited by 41
The role of VEGF in Cancer angiogenesis and tumorigenesis: Insights for anti-VEGF therapy
Shi, Z., Kuai, M., Li, B., Akowuah, C. F., Wang, Z., Pan, Y., Tang, M., Yang, X., & Lü, P. (2025) · Cytokine · doi:10.1016/j.cyto.2025.156908 · Cited by 37
CITED2 and the modulation of the hypoxic response in cancer
Fernandes, M. T., Calado, S. M., Mendes-Silva, L., & Bragança, J. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i5.260 · Cited by 30
Factor‐inhibiting HIF‐1 (FIH‐1) is required for human vascular endothelial cell survival
Kiriakidis, S., Henze, A., Kruszynska‐Ziaja, I., Skobridis, K., Theodorou, V., Paleolog, E. M., & Mazzone, M. (2015) · The FASEB Journal · doi:10.1096/fj.14-252379 · Cited by 34
Ruiz‐Llorente, S., Bravo, J., Cebrián, A., Cascón, A., Pollán, M., Tellería, D., Letón, R., Urioste, M., Rodríguez‐López, R., de Campos, J. M., et al. (2004) · Human Mutation · doi:10.1002/humu.10309 · Cited by 34
Role of the ubiquitin proteasome system in renal cell carcinoma
Corn, P. G. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-s1-s4 · Cited by 40
Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
Ou, L., Setegne, M. T., Elliot, J., Shen, F., & Dassama, L. M. K. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00595 · Cited by 33
Knauth, K., Cartwright, E. J. P., Freund, S. M. V., Bycroft, M., & Buchberger, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809056200 · Cited by 35
Erber, L. N., Luo, A., & Chen, Y. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001535 · Cited by 31
A positive feedback regulatory loop involving the lncRNA PVT1 and HIF-1α in pancreatic cancer
Zhu, Y., Wu, F., Gui, W., Zhang, N., Matro, E., Zhu, L., Eserberg, D. T., & Lin, X. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab042 · Cited by 32
“Structurally, HIF-1 is a heterodimeric transcription factor composed of HIF-1 a and HIF-1 b subunits (Hon et al., 2002 ).”
Progress of small molecules for targeted protein degradation: PROTACs and other technologies
Zhao, H., Xin, M., & Zhang, S. (2023) · Drug Development Research · doi:10.1002/ddr.22026 · Cited by 31
“On the foundation of the disclosed interaction between HIF‐1α and VHL, a heptapeptide (ALAPYIP) was excavated as the first VHL ligand (Hon et al., 2002).”
BackgroundInfluentialRöth, S., Kocatürk, N. M., Sathyamurthi, P. S., Carton, B., Watt, M., Macartney, T., Chan, K.-H., Isidro‐Llobet, A., Konopacka, A., Queisser, M. A., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2023.07.006 · Cited by 34
Willam, C., Nicholls, L. G., Ratcliffe, P. J., Pugh, C. W., & Maxwell, P. H. (2004) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2003.11.017 · Cited by 33
Self-citationChowdhury, A. R., Long, A., Fuchs, S. Y., Rustgi, A. K., & Avadhani, N. G. (2016) · Oncogene · doi:10.1038/onc.2016.211 · Cited by 29
Kim, Y.-J., Zhao, Y., Myung, J. K., Yi, J. M., Kim, M., & Lee, S. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109996 · Cited by 31
Chen, J., Ji, P., Gnawali, G. R., Chang, M., Gao, F., Xu, H., & Wang, W. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.018 · Cited by 33
A fluorescence polarization-based interaction assay for hypoxia-inducible factor prolyl hydroxylases
Cho, H.-J., Park, H., & Yang, E. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.041 · Cited by 29
Role of HIF in fish inflammation
Shi, X., Gao, F., Zhao, X., Pei, C., Zhu, L., Zhang, J., Li, C., Li, L., & Kong, X. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.109222 · Cited by 33
VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation
Wang, Z., Yan, M., Ye, L., Zhou, Q., Duan, Y., Jiang, H., Wang, L., Ouyang, Y., Zhang, H., Shen, Y., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00051-2 · Cited by 37
“To hydroxylate protein substrates, PHD requires oxygen as a co-substrate (Hon et al, 2002; Ivan and Kaelin, 2017).”
Fu, C., Tyagi, R., Chin, A. C., Rojas, T., Li, R.-J., Guha, P., Bernstein, I. A., Rao, F., Xu, R., Cha, J. Y., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.311983 · Cited by 28
Montgomery, N. T., Zientek, K. D., Pokidysheva, E. N., & Bächinger, H. P. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000406 · Cited by 28
“Post-translational modifications, including prolyl-hydroxylation of hypoxia-inducible factor 1- (HIF-1 ) to enable interaction with pVHL (12, 13), have a major role in altering protein–protein interactions.”
2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2
Mecinović, J., Loenarz, C., Chowdhury, R., & Schofield, C. J. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.005 · Cited by 30
Self-citationPerrotta, S., Stiehl, D. P., Punzo, F., Scianguetta, S., Borriello, A., Bencivenga, D., Casale, M., Nobili, B., Fasoli, S., Balduzzi, A., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.088369 · Cited by 33
Wottawa, M., Leisering, P., von Ahlen, M., Schnelle, M., Vogel, S., Malz, C. R., Bordoli, M. R., Camenisch, G., Hesse, A., Napp, J., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27982 · Cited by 31
Metadata
- Authors
- Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Jones, E. Yvonne
- ORCID
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6892
- Pages
- 975-978
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2167786713
- Cited by
- 751
- References
- 31
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 46 · 2023: 43 · 2022: 37 · 2021: 35 · 2020: 43 · 2019: 19 · 2018: 24 · 2017: 23 · 2016: 28 · 2015: 24 · 2014: 20 · 2013: 23 · 2012: 26
- FWCI
- 17.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- HIF-1α, von Hippel-Lindau protein, E3 ubiquitin ligase, hypoxia, oxygen sensing, protein-protein binding, crystal structure, hydrogen bonding, ubiquitination, proteasomal degradation, transcriptional regulation
- MeSH terms
- Elongin, Amino Acid Sequence, Hypoxia, Binding Sites, Humans, Hydrogen Bonding, Hydroxylation, Hydroxyproline, Kinetics, Ligases, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Structure-Activity Relationship, Substrate Specificity, Transcription Factors, Sequence Alignment, Crystallography, X-Ray, Surface Plasmon Resonance, Amino Acid Motifs, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.